Sodium-glucose co-transporter 2 inhibitors improve insulin resistance and β-cell function in type 2 diabetes: A meta-analysis

doi:10.4239/wjd.v16.i7.107335

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (663)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

HTML

352

Figures (1-3)

Tables (1-5)

Sum=546

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=63

Jul 15, 2025 (publication date) through Aug 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Diabetes. Jul 15, 2025; 16(7): 107335
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107335

Full Size Figure Download Figure

Figure 2 Forest plots for the meta-analyses comparing the influence of sodium-glucose cotransporter 2 inhibitors vs placebo on homeostasis model assessment of insulin resistance and β-cell function in patients with type 2 diabetes. A: Forest plot for the outcome of homeostasis model assessment of insulin resistance; B: Forest plot for the outcome of homeostasis model assessment of β-cell function. SGLT2: Sodium-glucose cotransporter 2; CI: Confidence interval.

Citation: Chai SY, Zhang RY, Ning ZY, Zheng YM, Swapnil R, Ji LN. Sodium-glucose co-transporter 2 inhibitors improve insulin resistance and β-cell function in type 2 diabetes: A meta-analysis. World J Diabetes 2025; 16(7): 107335
URL: https://www.wjgnet.com/1948-9358/full/v16/i7/107335.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i7.107335